The risks of cancer in patients taking medication for diabetes were analyzed by 2 recent studies.
Renal side effects of diabetes drugs were in the news in the past month, with one industry-funded study finding an association between empagliflozin and slower progression of kidney disease and the FDA strengthening an existing warning on risk of
The risk of heart failure in patients taking medication for type 2 diabetes was analyzed by 2 recent studies.
Three recent studies reanalyzed past data about the effects of intensive glycemic control and published new findings about how and which patients may benefit.
The possible role of viruses in the development of diabetes was analyzed by two recent studies.
Two recent studies highlighted some differences among ethnic groups in risk and incidence of diabetes.
Treatment of type 2 diabetes with bariatric surgery was discussed by several recent publications, including updated guidelines from a group of medical specialty organizations.
Two recent studies looked at cardiovascular disease (CVD) risk in women with type 2 diabetes, finding that fenofibrate may be associated with lowered risk and sulfonylureas with increased risk.
Knowledge among U.S. patients and clinicians about recommended care for diabetes is good but could still use improvement, one can conclude from studies published this month.
Intensive blood pressure control may increase diabetic patients' risk of stroke or coronary heart disease, a group of researchers recently concluded in two separate publications.